Register entry
Niagara Pharmaceuticals Inc.
- Registered sites
- 2
- Drug products
- 7
- Live patents
- 0
- Countries
- 2
- Base
- United States
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Active ingredient (API) manufactureFinished drug manufacture
Sites
Facilities
2| Site | Location | Operations | FEI |
|---|---|---|---|
| Niagara Pharmaceuticals, Inc | DundasCanada | Active ingredient (API) manufacture, Finished drug manufacture | 3003093882 |
| Niagara Pharmaceuticals LLC | Cowpens, SCUnited States | Finished drug manufacture | 3036791147 |
Catalogue
Marketed products
7Showing 7 of 7.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Eyewash Station Additive Concentrate | Chlorhexidine gluconate and Propylene Glycol | LIQUID | OTC MONOGRAPH DRUG |
| PUR-WASH | Water | SOLUTION | NDA |
| PUR-WASH | Water | SOLUTION | NDA |
| PUR-WASH | Water | SOLUTION | NDA |
| PUR-WASH | Water | SOLUTION | NDA |
| Pur-Wash | Eyewash | SOLUTION | NDA |
| ULINE Eyewash | Eyewash | SOLUTION | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.